series-a
Stage
1
Investors
About
Enumera Molecular develops a simplified, rapid, and cost-effective molecular counting platform called EnumeraPlex to enable liquid biopsy and high-dimensional clinical molecular testing for laboratories.
Explore Enumera Molecular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.